Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Comparison of the use of a toothpick holder to dental floss in improvement of gingival health in humans.

Lewis MW, Holder-Ballard C, Selders RJ Jr, Scarbecz M, Johnson HG, Turner EW.

J Periodontol. 2004 Apr;75(4):551-6.

PMID:
15152819
2.

In vivo and in vitro pharmacologic activity of the purine nucleoside phosphorylase inhibitor BCX-34: the role of GTP and dGTP.

Bantia S, Montgomery JA, Johnson HG, Walsh GM.

Immunopharmacology. 1996 Oct;35(1):53-63.

PMID:
8913795
5.

Effects of NSAIDs on beagle crevicular cyclooxygenase metabolites and periodontal bone loss.

Offenbacher S, Williams RC, Jeffcoat MK, Howell TH, Odle BM, Smith MA, Hall CM, Johnson HG, Goldhaber P.

J Periodontal Res. 1992 May;27(3):207-13.

PMID:
1608034
6.

Increased pulmonary production of immunoreactive 15-hydroxyeicosatetraenoic acid in an animal model of asthma.

Gray PR, Derksen FJ, Broadstone RV, Robinson NE, Johnson HG, Olson NC.

Am Rev Respir Dis. 1992 May;145(5):1092-7.

PMID:
1586052
7.

Activation of human eosinophils by platelet-derived growth factor.

Bach MK, Brashler JR, Stout BK, Johnson HG, Sanders ME, Lin AH, Gorman RR, Bienkowski MJ, Ishizaka T.

Int Arch Allergy Immunol. 1992;97(2):121-9.

PMID:
1316315
8.

Inhibition of alveolar bone loss in beagles with the NSAID naproxen.

Howell TH, Jeffcoat MK, Goldhaber P, Reddy MS, Kaplan ML, Johnson HG, Hall CM, Williams RC.

J Periodontal Res. 1991 Nov;26(6):498-501.

PMID:
1837054
9.

Biochemical and functional differences between eosinophils from animal species and man.

Sun FF, Crittenden NJ, Czuk CI, Taylor BM, Stout BK, Johnson HG.

J Leukoc Biol. 1991 Aug;50(2):140-50.

PMID:
1649240
10.
11.

Platelet-derived growth factor can activate purified primate, phorbol myristate acetate-primed eosinophils.

Bach MK, Brashler JR, Stout BK, Johnson HG, Sanders ME.

Int Arch Allergy Appl Immunol. 1991;94(1-4):167-8.

PMID:
1657791
12.

Expression of microtubule-associated protein 2 by reactive astrocytes.

Geisert EE Jr, Johnson HG, Binder LI.

Proc Natl Acad Sci U S A. 1990 May;87(10):3967-71.

13.

The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves.

Gray PR, Derksen FJ, Robinson NE, Carpenter-Deyo LJ, Johnson HG, Roth RA.

Am Rev Respir Dis. 1989 Jul;140(1):154-60.

PMID:
2502051
15.

Changes in cyclooxygenase metabolites in experimental periodontitis in Macaca mulatta.

Offenbacher S, Odle BM, Braswell LD, Johnson HG, Hall CM, McClure H, Orkin JL, Strobert EA, Green MD.

J Periodontal Res. 1989 Jan;24(1):63-74.

PMID:
2524572
16.

Ibuprofen: an inhibitor of alveolar bone resorption in beagles.

Williams RC, Jeffcoat MK, Howell TH, Reddy MS, Johnson HG, Hall CM, Goldhaber P.

J Periodontal Res. 1988 Jul;23(4):225-9. No abstract available.

PMID:
2972819
17.

Topical flurbiprofen treatment of periodontitis in beagles.

Williams RC, Jeffcoat MK, Howell TH, Reddy MS, Johnson HG, Hall CM, Goldhaber P.

J Periodontal Res. 1988 May;23(3):166-9. No abstract available.

PMID:
2969966
19.

Indomethacin or flurbiprofen treatment of periodontitis in beagles: effect on crevicular fluid arachidonic acid metabolites compared with effect on alveolar bone loss.

Williams RC, Offenbacher S, Jeffcoat MK, Howell TH, Johnson HG, Hall CM, Wechter WJ, Goldhaber P.

J Periodontal Res. 1988 Mar;23(2):134-8. No abstract available.

PMID:
2967365
20.
21.

Inhibitors of metal catalyzed lipid peroxidation reactions inhibit mucus secretion and 15 HETE levels in canine trachea.

Johnson HG, McNee ML, Braughler JM.

Prostaglandins Leukot Med. 1987 Dec;30(2-3):123-32.

PMID:
3122232
22.

Effects of flurbiprofen on the progression of periodontitis in Macaca mulatta.

Offenbacher S, Braswell LD, Loos AS, Johnson HG, Hall CM, McClure H, Orkin JL, Strobert EA, Green MD, Odle BM.

J Periodontal Res. 1987 Nov;22(6):473-81. No abstract available.

PMID:
2963107
23.

Indomethacin or flurbiprofen treatment of periodontitis in beagles: comparison of effect on bone loss.

Williams RC, Jeffcoat MK, Howell TH, Hall CM, Johnson HG, Wechter WJ, Goldhaber P.

J Periodontal Res. 1987 Sep;22(5):403-7. No abstract available.

PMID:
2961872
24.

Flurbiprofen treatment of periodontal disease in beagles.

Jeffcoat MK, Williams RC, Wechter WJ, Johnson HG, Kaplan ML, Gandrup JS, Goldhaber P.

J Periodontal Res. 1986 Nov;21(6):624-33. No abstract available.

PMID:
2947995
25.
26.
27.

Treatment of periodontal disease in beagles with lodoxamide ethyl, an inhibitor of mast cell release.

Jeffcoat MK, Williams RC, Johnson HG, Wechter WJ, Goldhaber P.

J Periodontal Res. 1985 Sep;20(5):532-41. No abstract available.

PMID:
2934538
28.

15-Hydroxyeicosatetraenoic acid is a potent inflammatory mediator and agonist of canine tracheal mucus secretion.

Johnson HG, McNee ML, Sun FF.

Am Rev Respir Dis. 1985 Jun;131(6):917-22.

PMID:
3923884
29.

Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles.

Williams RC, Jeffcoat MK, Kaplan ML, Goldhaber P, Johnson HG, Wechter WJ.

Science. 1985 Feb 8;227(4687):640-2.

PMID:
3969553
30.

Airway responses to aerosolized leukotriene D4 (LTD4) in normal and Ascaris reactor primates.

Johnson HG, Stout BK.

Prostaglandins. 1985 Feb;29(2):313-22.

PMID:
3983410
31.

Secretagogue action of adenosine in the in vivo canine tracheal mucus model.

Johnson HG, McNee ML, Johnson MA.

Int J Immunopharmacol. 1985;7(2):159-63.

PMID:
4008138
32.

Piriprost: a selective inhibitor of leukotriene synthesis.

Bach MK, Bowman BJ, Brashler JR, Fitzpatrick FA, Griffin RL, Johnson HG, Major NJ, McGuire JC, McNee ML, Richards IM, et al.

Adv Prostaglandin Thromboxane Leukot Res. 1985;15:225-7. No abstract available.

PMID:
2936098
33.

Non-steroidal anti-inflammatory drug treatment of periodontitis in beagles.

Williams RC, Jeffcoat MK, Wechter WJ, Johnson HG, Kaplan ML, Goldhaber P.

J Periodontal Res. 1984 Nov;19(6):633-7. No abstract available.

PMID:
6241242
34.

Regulation of canine mucus secretion by a novel leukotriene synthesis inhibitor (U-60,257).

Johnson HG, McNee ML.

Int Arch Allergy Appl Immunol. 1984;75(2):97-101.

PMID:
6432706
35.

Diphenhydramine blocks the leukotriene-C4 enhanced mucus secretion in canine trachea in vivo.

Johnson HG, Chinn RA, Morton DR, McNee ML, Miller MD, Nadel JA.

Agents Actions. 1983 Feb;13(1):1-4.

PMID:
6858783
36.

Secretogogue responses of leukotriene C4, D4: comparison of potency in canine trachea in vivo.

Johnson HG, McNee ML.

Prostaglandins. 1983 Feb;25(2):237-43.

PMID:
6856875
37.

Leukotriene C4 and dimethylphenylpiperazinium-induced responses in canine airway tracheal muscle contraction and fluid secretion.

Johnson HG, McNee ML, Johnson MA, Miller MD.

Int Arch Allergy Appl Immunol. 1983;71(3):214-8.

PMID:
6852945
38.

Leukotriene-C4 enhances mucus production from submucosal glands in canine trachea in vivo.

Johnson HG, Chinn RA, Chow AW, Bach MK, Nadel JA.

Int J Immunopharmacol. 1983;5(5):391-6.

PMID:
6654536
39.

The activity of a new, novel inhibitor of leukotriene synthesis in rhesus monkey Ascaris reactors.

Johnson HG, McNee ML, Bach MK, Smith HW.

Int Arch Allergy Appl Immunol. 1983;70(2):169-73.

PMID:
6337108
40.

In vivo and in vitro actions of a new selective inhibitor of leukotriene C and D synthesis.

Bach MK, Brashler JR, Fitzpatrick FA, Griffin RL, Iden SS, Johnson HG, McNee ML, McGuire JC, Smith HW, Smith RJ, Sun FF, Wasserman MA.

Adv Prostaglandin Thromboxane Leukot Res. 1983;11:39-44. No abstract available.

PMID:
6221551
41.

The synthesis of 6,9-deepoxy-6,9-N-phenylimino-delta 6,8-prostaglandin I1. A novel inhibitor of leukotriene C and D synthesis.

Smith HW, Bach MK, Harrison AW, Johnson HG, Major NJ, Wasserman MA.

Prostaglandins. 1982 Oct;24(4):543-6.

PMID:
6817384
42.

Privacy and confidentiality in psychotherapy.

Everstine L, Everstine DS, Heymann GM, True RH, Frey DH, Johnson HG, Seiden RH.

Am Psychol. 1980 Sep;35(9):828-40. No abstract available.

PMID:
7416570
43.

1-[Ethoxyamino)methyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2-benzoxepins: a new class of antianaphylactic agents.

TenBrink RE, McCall JM, Johnson HG.

J Med Chem. 1980 Sep;23(9):1058-60.

PMID:
7411551
44.

Serotonergic approaches to the modification of behavior in the Lesch-Nyhan Syndrome.

Nyhan WL, Johnson HG, Kaufman IA, Jones KL.

Appl Res Ment Retard. 1980;1(1-2):25-40. No abstract available.

PMID:
6978104
45.
46.
48.
49.

N,N'-(Phenylene)dioxamic acids and their esters as antiallergy agents.

Wright JB, Hall CM, Johnson HG.

J Med Chem. 1978 Sep;21(9):930-5.

PMID:
102796
50.

Supplemental Content

Loading ...
Support Center